TargTex Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Investors
  • 7

TargTex General Information

Description

Operator of a biotech company intended to treat glioblastoma multiforme. The company's therapeutics specializes in artificial intelligence algorithms that decipher a relationship between an unexplored target, like a calcium channel, and a small molecule with known anti-cancer properties, enabling scientists, physicians, and patients to have clinical candidates for different oncological indications.

Contact Information

Website
www.targtex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenida Tenente Valadim
  • Number 17, 2nd Floor
  • Torres Vedras, 2560-275
  • Portugal
+351 21
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Avenida Tenente Valadim
  • Number 17, 2nd Floor
  • Torres Vedras, 2560-275
  • Portugal
+351 21

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TargTex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 14-Oct-2026 In Progress Generating Revenue
5. Grant 21-Jun-2023 Completed Generating Revenue
4. Later Stage VC 14-Feb-2022 Completed Generating Revenue
3. Grant 27-Nov-2019 Completed Generating Revenue
2. Seed Round 26-Jun-2019 $1.41M $1.41M Completed Startup
1. University Spin-Out 01-Jun-2019 Completed Startup
To view TargTex’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TargTex Patents

TargTex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024400179-A1 Chemotherapeutic agent and compositions Pending 12-Dec-2023
EP-4823540-A1 Chemotherapeutic agent and compositions Pending 12-Dec-2023
WO-2025125509-A1 Chemotherapeutic agent and compositions Inactive 12-Dec-2023 A61K9/0085

TargTex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TargTex Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
Laboratorios Basi Corporation Minority
Horizon 2020 Government
Ignition Capital Venture Capital Minority
Portugal Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

TargTex FAQs

  • When was TargTex founded?

    TargTex was founded in 2019.

  • Where is TargTex headquartered?

    TargTex is headquartered in Torres Vedras, Portugal.

  • What is the size of TargTex?

    TargTex has 9 total employees.

  • What industry is TargTex in?

    TargTex’s primary industry is Drug Discovery.

  • Is TargTex a private or public company?

    TargTex is a Private company.

  • What is TargTex’s current revenue?

    The current revenue for TargTex is .

  • How much funding has TargTex raised over time?

    TargTex has raised $3.67M.

  • Who are TargTex’s investors?

    European Innovation Council, Laboratorios Basi, Horizon 2020, Ignition Capital, and Portugal Ventures are 5 of 7 investors who have invested in TargTex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process